AcceGen, USA

AcceGen is a U.S.-based biotechnology company that offers a wide range of cell-based models and molecular biology products. Its portfolio includes over 1,900 primary cell types, more than 1,200 cancer cell lines, over 42,000 stable cell lines, more than 600 stem cell products, over 200 immortalized cell lines, approximately 130 nucleic acid kits, and more than 5,290 microRNA agomirs and antagomirs.